Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancers|May 14, 2022
The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective ImmunotherapiesMalcolm Holterhus, Bianca Altvater, Sareetha Kailayangiri, et al.
Frontiers in Oncology|November 29, 2018
Carbohydrate Targets for CAR T Cells in Solid Childhood CancersClaudia Rossig, Sareetha Kailayangiri, Silke Jamitzky, et al.
Cancers|May 3, 2020
Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of CancersSareetha Kailayangiri, Bianca Altvater, Malena Wiebel, et al.
Pediatric Blood & Cancer|July 31, 2020
VEGFR2 as a target for CAR T cell therapy of Ewing sarcomaAlexander Englisch, Bianca Altvater, Sareetha Kailayangiri, et al.
STAR Protocols|July 24, 2024
Protocol for assessing GD2 on formalin-fixed paraffin-embedded tissue sections using immunofluorescence stainingSareetha Kailayangiri, Bianca Altvater, Nicole Farwick, et al.
Cancer Reports (Hoboken, N.J.)|April 3, 2021
Surface expression of the immunotherapeutic target GD2 in osteosarcoma depends on cell confluencyMalena Wiebel, Sareetha Kailayangiri, Bianca Altvater, et al.
Cancer Immunology, Immunotherapy : CII|September 20, 2011
Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigensBianca Altvater, Sibylle Pscherer, Silke Landmeier, et al.
The Journal of Biological Chemistry|March 2, 2013
The ubiquitin-fold modifier 1 (Ufm1) cascade of Caenorhabditis elegansPatrick Hertel, Jens Daniel, Dirk Stegehake, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2021
SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cellsMeriem Bahri, Sareetha Kailayangiri, Sarah Vermeulen, et al.
Pageof 3